Alerts will be sent to your verified email
Verify Email
SHAMROIN
|
Shamrock Indl. Co
|
Chemo Pharma Labs
|
Norris Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-8.9 % | -4.51 % | 47.03 % |
|
5yr average Equity Multiplier
|
1.02 | 1.01 | -2.46 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.0 | 0.6 |
|
5yr Avg Net Profit Margin
|
0.0 | 0.0 | -30.66 % |
|
Price to Book
|
11.85 | 1.45 | 0.0 |
|
P/E
|
0.0 | 56.22 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 97.28 Days |
|
Inventory Days
|
0.0 | 0.0 | 165.43 Days |
|
Days Receivable
|
0.0 | 0.0 | 69.98 Days |
|
Days Payable
|
68.55 Days | 0.0 | 260.51 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | 794.39 | -1.37 |
|
5yr Avg ROCE
|
-8.89 % | -3.17 % | -19.87 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 0.0 | -6.94 % |
|
5 yr average Debt to Equity
|
0.0 | 0.01 | -3.0 |
|
5yr CAGR Net Profit
|
-28.89 % | n/a | -15.97 % |
|
5yr Average Return on Assets
|
-8.72 % | -4.13 % | -18.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
42.98 % | 27.89 % | 34.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Chemo Pharma Labs
|
Norris Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|